{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T13:11:47Z","timestamp":1787663507790,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","issue":"46","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T00:00:00Z","timestamp":1663804800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["H29-SHINKOGYOSEI-SHITEI \\u2212003"],"award-info":[{"award-number":["H29-SHINKOGYOSEI-SHITEI \\u2212003"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["20HA2001"],"award-info":[{"award-number":["20HA2001"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018376","name":"Sapporo Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018376","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017094","name":"Department of Internal Medicine, University of Utah","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017094","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.vaccine.2022.09.055","type":"journal-article","created":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T23:40:50Z","timestamp":1664494850000},"page":"6589-6598","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against community-acquired pneumonia in older individuals after the introduction of childhood 13-valent pneumococcal conjugate vaccine: A multicenter hospital-based case-control study in Japan"],"prefix":"10.1016","volume":"40","author":[{"given":"Kei","family":"Nakashima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanzo","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Aoshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayumi","family":"Murabata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoko","family":"Ohfuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wakaba","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Hirota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2022.09.055_b0005","unstructured":"World Health Organization. Fact sheets: the top 10 causes of death. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/the-top-10-causes-of-death."},{"key":"10.1016\/j.vaccine.2022.09.055_b0010","doi-asserted-by":"crossref","unstructured":"Moberley S, Holden J, Tatham DP, Andrews RM. Vaccines for preventing pneumococcal infection in adults. The Cochrane database of systematic reviews. 2013:CD000422.","DOI":"10.1002\/14651858.CD000422.pub3"},{"issue":"12","key":"10.1016\/j.vaccine.2022.09.055_b0015","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa1408544","article-title":"Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults","volume":"372","author":"Bonten","year":"2015","journal-title":"The New England j med"},{"key":"10.1016\/j.vaccine.2022.09.055_b0020","unstructured":"Nuorti JP, Whitney CG, Centers for Disease C, Prevention. Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommendations and reports : Morbidity and mortality weekly report Recommendations and reports. 2010;59:1-18."},{"key":"10.1016\/j.vaccine.2022.09.055_b0025","unstructured":"Pneumococcal vaccines WHO position paper\u20142012. Wkly Epidemiol Rec. 2012;87:129-44"},{"key":"10.1016\/j.vaccine.2022.09.055_b0030","doi-asserted-by":"crossref","unstructured":"Lucero MG, Dulalia VE, Nillos LT, Williams G, Parreno RA, Nohynek H, et al. Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and X-ray defined pneumonia in children less than two years of age. The Cochrane database of systematic reviews. 2009:CD004977.","DOI":"10.1002\/14651858.CD004977.pub2"},{"issue":"43","key":"10.1016\/j.vaccine.2022.09.055_b0035","doi-asserted-by":"crossref","first-page":"7063","DOI":"10.1016\/j.vaccine.2010.08.010","article-title":"Effectiveness of pneumococcal polysaccharide vaccine against pneumonia and cost analysis for the elderly who receive seasonal influenza vaccine in Japan","volume":"28","author":"Kawakami","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.09.055_b0040","doi-asserted-by":"crossref","unstructured":"Maruyama T, Taguchi O, Niederman MS, Morser J, Kobayashi H, Kobayashi T, et al. Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trial. BMJ (Clinical research ed). 2010;340:c1004-c.","DOI":"10.1136\/bmj.c1004"},{"issue":"3","key":"10.1016\/j.vaccine.2022.09.055_b0045","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S1473-3099(17)30049-X","article-title":"Serotype-specific effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia in adults aged 65 years or older: a multicentre, prospective, test-negative design study","volume":"17","author":"Suzuki","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2022.09.055_b0050","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1080\/21645515.2019.1584023","article-title":"Preventive effects of pneumococcal and influenza vaccines on community-acquired pneumonia in older individuals in Japan: a case-control study","volume":"15","author":"Suzuki","year":"2019","journal-title":"Human vaccines & immunotherapeutics"},{"issue":"10","key":"10.1016\/j.vaccine.2022.09.055_b0055","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S1473-3099(11)70090-1","article-title":"Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study","volume":"11","author":"Miller","year":"2011","journal-title":"Lancet Infect Dis"},{"issue":"20","key":"10.1016\/j.vaccine.2022.09.055_b0060","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1016\/j.vaccine.2019.04.009","article-title":"Impact of the pediatric 13-valent pneumococcal conjugate vaccine on serotype distribution and clinical characteristics of pneumococcal pneumonia in adults: the japan pneumococcal vaccine effectiveness Study (J-PAVE)","volume":"37","author":"Sando","year":"2019","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2022.09.055_b0065","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1136\/thoraxjnl-2018-211767","article-title":"Effect of childhood pneumococcal conjugate vaccination on invasive disease in older adults of 10 European countries: implications for adult vaccination","volume":"74","author":"Hanquet","year":"2019","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.vaccine.2022.09.055_b0070","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S1473-3099(18)30052-5","article-title":"Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000\u201317: a prospective national observational cohort study","volume":"18","author":"Ladhani","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2022.09.055_b0075","doi-asserted-by":"crossref","DOI":"10.3201\/eid2007.131485","article-title":"Changes in capsule and drug resistance of pneumococci after introduction of PCV7, Japan, 2010\u20132013","volume":"20","author":"Chiba","year":"2014","journal-title":"Emerg Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2022.09.055_b0080","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.3201\/eid2411.180326","article-title":"Effects of pneumococcal conjugate vaccine on genotypic penicillin resistance and serotype changes, Japan, 2010\u20132017","volume":"24","author":"Ubukata","year":"2018","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2022.09.055_b0085","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jiac.2019.12.011","article-title":"The estimated impact of the 5-year national vaccination program on the trend of 23-valent pneumococcal polysaccharide vaccine vaccination rates in the elderly in Japan, 2009\u20132018","volume":"26","author":"Naito","year":"2020","journal-title":"J Infection and Chemotherapy"},{"issue":"36","key":"10.1016\/j.vaccine.2022.09.055_b0090","doi-asserted-by":"crossref","first-page":"4806","DOI":"10.1016\/j.vaccine.2017.07.005","article-title":"Effectiveness of 23-valent pneumococcal polysaccharide vaccine and seasonal influenza vaccine for pneumonia among the elderly - Selection of controls in a case-control study","volume":"35","author":"Kondo","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.09.055_b0095","doi-asserted-by":"crossref","unstructured":"Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al. Infectious Diseases Society of America\/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults. Clinical Infectious Diseases. 2007;44:S27-S72.","DOI":"10.1086\/511159"},{"issue":"11","key":"10.1016\/j.vaccine.2022.09.055_b0100","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1136\/thoraxjnl-2013-204282","article-title":"Risk factors for community-acquired pneumonia in adults in Europe: a literature review","volume":"68","author":"Torres","year":"2013","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.vaccine.2022.09.055_b0105","doi-asserted-by":"crossref","DOI":"10.1186\/s12874-016-0159-6","article-title":"Identification of confounder in epidemiologic data contaminated by measurement error in covariates","volume":"16","author":"Lee","year":"2016","journal-title":"BMC Med Res Method"},{"key":"10.1016\/j.vaccine.2022.09.055_b0110","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/oxfordjournals.aje.a116813","article-title":"Simulation study of confounder-selection strategies","volume":"138","author":"Maldonado","year":"1993","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2022.09.055_b0115","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/oxfordjournals.aje.a115101","article-title":"The impact of confounder selection criteria on effect estimation","volume":"129","author":"Mickey","year":"1989","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.vaccine.2022.09.055_b0120","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3181\/00379727-173-41643","article-title":"Long-term persistence of antibody following immunization with pneumococcal polysaccharide vaccine","volume":"173","author":"Mufson","year":"1983","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.vaccine.2022.09.055_b0125","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/cid\/ciy872","article-title":"Impact of the 13-Valent Pneumococcal Conjugate Vaccine Among Adults: A Systematic Review and Meta-analysis","volume":"69","author":"Vadlamudi","year":"2019","journal-title":"Clinical infectious diseases : an official publication of the Infectious Dise Soc Ama"},{"issue":"5","key":"10.1016\/j.vaccine.2022.09.055_b0130","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1017\/S0950268805004012","article-title":"A longitudinal household study of Streptococcus pneumoniae nasopharyngeal carriage in a UK setting","volume":"133","author":"Hussain","year":"2005","journal-title":"Epidemiol Infect"},{"issue":"12","key":"10.1016\/j.vaccine.2022.09.055_b0135","doi-asserted-by":"crossref","first-page":"5628","DOI":"10.1080\/21645515.2021.1985353","article-title":"Epidemiology of non-vaccine serotypes of Streptococcus pneumoniae before and after universal administration of pneumococcal conjugate vaccines","volume":"17","author":"Du","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2022.09.055_b0140","doi-asserted-by":"crossref","unstructured":"Lawrence H, Pick H, Baskaran V, Daniel P, Rodrigo C, Ashton D, et al. Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against vaccine serotype pneumococcal pneumonia in adults: A case-control test-negative design study. PLOS Medicine. 2020;17:e1003326.","DOI":"10.1371\/journal.pmed.1003326"},{"issue":"21","key":"10.1016\/j.vaccine.2022.09.055_b0145","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1016\/j.vaccine.2019.04.017","article-title":"Direct effectiveness of pneumococcal polysaccharide vaccine against invasive pneumococcal disease and non-bacteremic pneumococcal pneumonia in elderly population in the era of pneumococcal conjugate vaccine: A case-control study","volume":"37","author":"Kim","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.09.055_b0150","doi-asserted-by":"crossref","unstructured":"Heo JY, Seo YB, Choi WS, Kim EJ, Jeong HW, Lee J, et al. Effectiveness of Pneumococcal Vaccination Against Pneumococcal Pneumonia Hospitalization in Older Adults: A Prospective, Test-Negative Study. The Journal of Infectious Diseases. 2021.","DOI":"10.1093\/infdis\/jiab474"},{"key":"10.1016\/j.vaccine.2022.09.055_b0155","doi-asserted-by":"crossref","first-page":"11051","DOI":"10.1038\/s41598-018-29280-2","article-title":"Pneumococcal Disease and the Effectiveness of the PPV23 Vaccine in Adults: a two-stage bayesian meta-analysis of observational and RCT Reports","volume":"8","author":"Latifi-Navid","year":"2018","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.vaccine.2022.09.055_b0160","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/14760584.2021.1880328","article-title":"Efficacy and effectiveness of a 23-valent polysaccharide vaccine against invasive and noninvasive pneumococcal disease and related outcomes: a review of available evidence","volume":"20","author":"Niederman","year":"2021","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2022.09.055_b0165","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.15585\/mmwr.mm6846a5","article-title":"Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged >\/=65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices","volume":"68","author":"Matanock","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"10.1016\/j.vaccine.2022.09.055_b0170","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1093\/pubmed\/fdt011","article-title":"Invasive pneumococcal disease and socioeconomic deprivation: a population study from the North East of England","volume":"35","author":"Chapman","year":"2013","journal-title":"J Public Health"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2201163X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2201163X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T08:18:15Z","timestamp":1777537095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2201163X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":34,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0264410X2201163X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.09.055","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against community-acquired pneumonia in older individuals after the introduction of childhood 13-valent pneumococcal conjugate vaccine: A multicenter hospital-based case-control study in Japan","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.09.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}